Loading…
Changzhou Qianhong Bio-pharma has started construction of the second phase of its manufacturing plant in Changzhou National Hi-Tech District, investing ¥1 billion ($145 million). The facility will produce innovative biologic drugs, adding 200 million tablets and 60 million injections annually.
| Site | Largest | Latest |
|---|---|---|
| Changzhou National Hi-Tech District, China | $145.0M | 2018-12-05 |